Target intelligence / Profile preview

Heparan sulfate glycosaminoglycan (HSGAG) (HSGAG)

Target
HSGAG
Molecular classification
Glycosaminoglycan, Polysaccharide, Extracellular matrix component, Co-receptor
01

Overview

Heparan sulfate glycosaminoglycans (HSGAGs) are complex, linear polysaccharides found on the cell surface and within the extracellular matrix of almost all animal tissues (Bishop et al., 2007, Nature). They consist of repeating disaccharide units that undergo extensive enzymatic modifications, such as sulfation and epimerization, creating specific patterns that serve as docking sites for hundreds of signaling proteins (Sarrazin et al., 2011, Cold Spring Harb Perspect Biol). By acting as essential co-receptors, HSGAGs regulate the activity of growth factors like FGF and VEGF, thereby controlling cell proliferation, migration, and tissue development (Knelson et al., 2014, Nat Rev Cancer). In disease, HSGAGs are frequently dysregulated; for instance, cancer cells overexpress the enzyme heparanase to degrade HSGAGs, facilitating tumor invasion and angiogenesis (Vlodavsky et al., 2012, Matrix Biology). Additionally, many pathogens, including SARS-CoV-2 and herpes simplex virus, utilize HSGAGs as initial attachment receptors to facilitate host cell entry (Clausen et al., 2020, Cell). Therapeutic interventions include heparin mimetics designed to competitively inhibit these interactions or small molecules that block heparanase activity (Hammond et al., 2014, J Med Chem). However, the structural complexity of HSGAGs and their broad physiological roles make achieving high therapeutic specificity a significant challenge for drug development.

Other names
Heparan sulfateHSHS-GAGHeparan sulphate
02

Mechanism of action

Competitive inhibition of ligand binding to cell-surface HSGAGs and inhibition of the endoglycosidase heparanase to prevent extracellular matrix remodeling.

03

Biological functions

Signal transductionCell adhesionGrowth factor sequestrationAngiogenesisViral entry mediation
04

Disease associations

CancerInflammationInfectionNeurodegenerative diseaseMucopolysaccharidosis
05

Safety considerations

Risk of hemorrhage due to heparin-like anticoagulant activityOff-target inhibition of essential growth factor signalingSystemic toxicity of highly charged polyanions
06

Interacting drugs

Muparfostat

4 more in the full profile.

07

Biomarkers

Heparanase expression levelsSyndecan-1 plasma levelsUrinary glycosaminoglycan levels

Beyond the preview

Go deeper on Heparan sulfate glycosaminoglycan (HSGAG) (HSGAG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heparan sulfate glycosaminoglycan (HSGAG) (HSGAG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call